Morning Overview on MSN
The brain has a hidden repair mode that can restore vision after injury
Vision loss has long been treated as a one-way street, a devastating endpoint rather than a problem the brain might quietly ...
When one eye is deprived of vision early in life, it can lead to amblyopia, a condition more commonly known as lazy eye. This happens because a lack of input disrupts synapse formation in the brain's ...
Scientists have found that an existing drug, already used in humans to treat alcohol use disorder, could help restore vision lost to conditions like age-related macular degeneration and retinitis ...
The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...
Please provide your email address to receive an email when new articles are posted on . Advanced Research Projects Agency for Health has launched a program to restore vision through whole eye ...
Please provide your email address to receive an email when new articles are posted on . Retinal implants have a history of challenges, and questions remain about their utility. A bioengineered RPE ...
For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...
People with severe vision loss have been able to read again, thanks to a tiny wireless chip implanted in one of their eyes and a pair of high-tech glasses. Age-related macular degeneration (AMD) is a ...
The case marks the first time sight has been partially restored using optogenetics, a type of biological research aimed at controlling nerve cells via light. Jackson Ryan was CNET's science editor, ...
The Science Eye is an intriguing piece of technology. Developed by Science Corp., the bionic eye seeks to restore vision in patients suffering from a variety of vision-based diseases. But, it also ...
The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. RV-001 a gene-agnostic approach for RP patients.
Technologies to compensate for limited sight have come a long way from the invention of Braille in the 1800s, but scientists are hoping to still take this a step further and restore vision altogether.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results